| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Corresponding author: James A. Birchler, 117 Tucker Hall, University of Missouri, Columbia, MO 65211-7400., birchlerj{at}missouri.edu (E-mail)
Communicating editor: S. HENIKOFF
| ABSTRACT |
|---|
The evolution of sex determination mechanisms is often accompanied by reduction in dosage of genes on a whole chromosome. Under these circumstances, negatively acting regulatory genes would tend to double the expression of the genome, which produces compensation of the single-sex chromosome and increases autosomal gene expression. Previous work has suggested that to reduce the autosomal expression to the female level, these dosage effects are modified by a chromatin complex specific to males, which sequesters a histone acetylase to the X. The reduced autosomal histone 4 lysine 16 (H4Lys16) acetylation results in lowered autosomal expression, while the higher acetylation on the X is mitigated by the male-specific lethal complex, preventing overexpression. In this report, we examine how mutations in the principal sex determination gene, Sex lethal (Sxl), impact the H4 acetylation and gene expression on both the X and autosomes. When Sxl expression is missing in females, we find that the sequestration occurs concordantly with reductions in autosomal H4Lys16 acetylation and gene expression on the whole. When Sxl is ectopically expressed in SxlM mutant males, the sequestration is disrupted, leading to an increase in autosomal H4Lys16 acetylation and overall gene expression. In both cases we find relatively little effect upon X chromosomal gene expression.
THE evolution of sex determination mechanisms is often accompanied by changes in chromosomal structure (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The generation of heteromorphic sex chromosomes, such as the X/Y situation in Drosophila and mammals, results in changes in the dosage of hundreds or thousands of genes. Typically, similar changes experimentally produced as aneuploids result in rather detrimental effects on vigor and, in extreme cases, lethality. These effects, which are thought to be a consequence of the dosage-sensitive regulatory genes (![]()
![]()
![]()
![]()
The most common dosage effect is one in which there is an inverse correlation between the regulatory gene dosage and the expression of the target loci (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
X inactivation in mammals and the male-specific lethal (MSL) complex in Drosophila have been considered as dosage compensation mechanisms. In fact, they appear to be reactionary modifications to the trans-acting dosage effects that are generated by the evolution of heteromorphic sex chromosomes (![]()
![]()
![]()
![]()
![]()
![]()
SEX LETHAL is a female-specific RNA-binding protein that controls alternative splicing in the sex determination cascade (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
In this article, we examine the effect of Sxl mutations on MSL protein sequestration and histone acetylation as well as on X and autosomal gene expression. Previously published models of Sxl action have suggested that loss of function in females results in increased expression of the X chromosomes and that ectopic expression of SXL in males eliminates X-chromosome dosage compensation. Our data indicate that the predominant role of Sxl can be understood within the context of modifying the sequestration of the MSL complex, which alters the impact of the dosage of the X chromosome.
| MATERIALS AND METHODS |
|---|
Crosses:
The following crosses were performed to generate the segregating classes for the Northern and Western blots as well as immunostaining: (1) mlepml 8/mlepml 8 females x mlepml 8/T(2;3)CyO Tb males. This cross produces males and females that are homozygous for mle and that can be distinguished by their normal appearance at the third larval instar. Control males and females are also produced that are heterozygous for mle and that have a Tubby phenotype. (2) y SxlM#4/Basc females x y/Y males. This cross produces brothers that are y SxlM#4 or normal Basc (y+) as well as females heterozygous for SxlM#4 with a yellow phenotype and those heterozygous for the Basc (y+) balancer. (3) y Sxlfhv#1/y Sxlfhv#1 females x Sxlf#1/Y males. The Sxl heteroallelic daughters produced from this cross have low viability in contrast to the normal Sxlfhv#1 males. (4) cm Sxlfhv#1 ct/cm Sxlfhv#1 ct; mlepml 8/mlepml 8 females x Sxlf#1 oc ptg v/Y; mlepml 8/In(2LR) Gla Bc Elp males. This cross produces heteroallelic females that are either homozygous for mle or heterozygous. The latter exhibit the Black cell (Bc) phenotype. The Sxlfhv#1/Y males are also segregating for mle.
Northern blots:
RNA preparations, electrophoresis of total mRNA, blotting to nylon membranes, hybridization, and antisense RNA preparation were performed as described (![]()
![]()
Because the major portion of total RNA is rRNA, it is possible to address the question of whether equivalent amounts of total RNA from different genotypes is contributed from equal amounts of DNA. This determination allows one to test whether each Sxl mutation affects the cellular expression of rRNA. Normalization of the values of each gene in the survey to rRNA provides a means to make a "per cell" expression comparison among Sxl genotypes. Analysis of total DNA/rRNA ratios for all the Sxl, mle, and Sxl; mle genotypes was performed as described previously (![]()
|
Western blots:
Crude extracts were prepared from third instar larvae using Laemmli loading buffer (10 µl/larvae) containing proteinase inhibitors as described (![]()
Immunostaining:
Polytene chromosomes from the third instar larvae were prepared as described (![]()
![]()
![]()
![]()
For confocal microscopy, Cy-5-conjugated goat secondary antibodies were used. The slides were mounted with Vectashield mounting media and propidium iodide mixture. The slides were examined with a Bio-Rad 600 confocal microscope (Bio-Rad, Richmond, CA) using a x100 oil lens.
| RESULTS |
|---|
The rationale for these experiments was to examine how loss- and gain-of-function alleles of Sxl affect the genomic distribution of MOF and hence histone 4 acetylation, which has not been determined previously. In examining the distribution of various MSL proteins, MOF, and histone acetylation, we used mixtures of salivary gland polytene chromosomes of the mutant genotypes with the appropriate male or female control so that any changes in either the X or the autosomes could be detected under the same conditions of preparation and analysis. In parallel, a survey of X and autosomal gene expression was conducted and correlated with the respective acetylation levels to establish the role of Sxl in modifying the trans-acting dosage effects of the X chromosome.
Binding of MSL proteins:
Loss of function of Sxl results in female lethality. However, certain alleles of the Sxl gene partially complement to give viable heteroallelic individuals. One combination is Sxlf#1/Sxlfhv#1, in which a few percent of the female progeny can survive to the third instar larval stage. In each individual, ~50% of the cells produce functional SXL protein (![]()
![]()
![]()
![]()
|
|
We next examined the X chromosomal association of MSL proteins in larvae carrying the gain-of-function allele SxlM#4. Individuals with this mutation have a constitutive expression of SXL protein in males that accumulates during development more slowly than it occurs in normal females (![]()
|
To determine whether the low level of MSL-2 binding is due to a reduced total amount in the SxlM males, we performed Western blot analysis using MSL-2 and MLE probes. MLE acts as a loading control because it was found in all genotypes tested (except the Sxl; mle females). The amount of MSL-2 protein is reduced in the SxlM male larvae relative to their controls (Fig 3), confirming that expression of the female-specific form of SXL in SxlM reduces the MSL-2 levels.
Given the residual binding of the MSL complex in these larvae, the question arises as to the basis of their male lethality. One possibility is that the MOF acetylase is incompletely sequestered to the X chromosome. To determine whether the reduced level of MSL-2 protein causes failure to sequester acetylase to the male X, a mixture of SxlM and normal male nuclei were examined in the same microscopic field using antibodies against MOF. A preferential labeling of the X was found in the wild-type nuclei, while the acetylase levels show a uniform genomewide distribution in the SxlM larvae (Fig 4B), as previously found in mle males and wild-type females (![]()
To confirm that the reduced level of MSL-2 is responsible for the female type of MOF distribution in the SxlM larvae, we used a transgenic stock, H83M2, which ectopically expresses the MSL-2 protein even in the presence of SXL protein (![]()
|
The double-mutant Sxl; msl flies are phenotypically intersex and contain a mixture of female and male cells. They survive at a high percentage relative to each single mutant. By removing a member of the MSL complex using an msl mutation, it should be possible to eliminate the sequestration of the MSL complex on the Xs, which otherwise occurs in the Sxl mutant. Therefore, we double stained a mixture of Sxlf/Sxlfhv and Sxlf/Sxlfhv; mlepml 8/mlepml 8 chromosomes with anti-MSL-1 and H4Ac16 antibodies and in separate preparations with anti-MLE and anti-MOF. In the former genotype, MSL-1 and MLE are either present only on the X chromosome (in the non-SXL-expressing cells) or uniformly distributed, as normally occurs in females. In the double-mutant genotype, there is no labeling with MLE in any of the cells. It has been noted previously for the X chromosome by ![]()
![]()
![]()
|
Gene expression:
Gene expression studies are important to define the effect of changes in histone acetylation on both the X and the autosomes. To determine the relationship between the mutational effect on gene expression and the sex-specific sequestration of MSL proteins and acetylase, we performed Northern analyses with total RNA on the same classes of mutant larvae that were studied in the binding assays. Steady-state mRNA levels were measured with randomly selected probes for 9 X-linked and 11 autosomal loci. Ribosomal RNA served as a gel-loading control. Individual genes react differently to the changes in histone acetylation, but general trends were evident with each type of mutant. In SxlM#4 and mlepml 8 males, most of the X-linked transcripts remain unaffected, relative to normal males, represented by Basc/Y and mle/+, respectively. However, the rudimentary and vermilion mRNA were significantly increased, while sis-b and Sgs-4 were reduced in both mutants (Fig 7 and Fig 8). In addition, the majority of the 11 tested autosomal loci were increased in their expression. Overall, these results suggest that the basis of the male lethality either by mlepml 8 or SxlM#4 results from a similar trend of effects on X and autosomal gene expression. It appears that the effect of mle and SxlM on X chromosomal RNA levels is negligible, whereas a general elevation in expression is found for autosomal loci. The latter trend correlates with an autosomal increase of H4Lys16 acetylation found in the antibody-labeling experiments described above.
|
|
For the X-linked transcripts in the Sxlf#1/Sxlfhv#1 heteroallelic females, the expression of the majority of transcripts was unchanged (Fig 7 and Fig 8). However, transcript levels of all 11 tested autosomal loci were altered significantly. The scarlet and Gpdh RNAs showed an elevation, whereas the majority of loci were reduced in expression relative to the Sxlfhv males in the same genetic background (Fig 7 and Fig 8). Because these females are mosaics of normal and SXL- cells (![]()
RNA analysis was also performed on the double-mutant Sxl; mle larvae. In this case, the homozygous mle mutation would hinder the sequestration of MOF to the X that occurs otherwise in the SXL- cells. To evaluate the fraction of cells expressing the different forms of Sxl in the Sxl and mle genotypes and to compare this value to the Western blots of Sxlf alone (described above), a Northern analysis of Sxl RNA was performed. The size of the Sxl transcript differs depending on the sex. Using this size difference as a marker, we were able to determine the percentage of male- and female-specific cells present in the mosaic larvae using a quantitative Northern blot, assuming minimal effect of Sxl on its own total RNA expression. Indeed, the total RNA from Sxl is not obviously different between the mutant and normal females and the intermediate level of the female form matches the level of protein found in the Western analysis noted above. These results indicate that Sxl has little impact on the level of its own total RNA (although due to the splicing function, the level of SXL protein is altered). Both male- and female-specific transcripts are present in the Sxl; mle genotype. Triplicate measurements relative to the rRNA control revealed that 54% of total Sxl mRNA is male specific (Fig 7 and Fig 8). Because this value is quite similar to the percentage found in Sxlf alone, there is a similar number of male and female cells in the two genotypes, which allows a direct comparison of the effects on gene expression.
For the X chromosome, the level of the majority of transcripts is not significantly different from those of the Sxl/Y; mle/+ males produced in the same cross (Fig 7 and Fig 8). Of the autosomal loci, the majority of the transcripts in such females was quite similar in level to that of control males. Thus, the blockage of the MOF sequestration by the mle mutation prevents the reduced autosomal expression that otherwise occurs in Sxlf females. Differences in gene expression between Sxl; mle females and mle females (![]()
![]()
| DISCUSSION |
|---|
In this study, the effect of Sxl mutations was examined to define the relationship of the sex determination mechanism to the sequestration process. In SxlM males, the slow accumulation of the SXL protein during development eventually prevents significant MSL-2 expression and hence reduces the MSL complex association with the X chromosome. This results in X and autosomal gene expression quite similar to that found in the mle mutant, i.e., little response of the X-linked genes, but an overall increase in autosomal expression (Fig 9). Similarly, the association of the MSL proteins in ~50% of the cells of heteroallelic Sxl females causes sequestration of MOF to the two X chromosomes. This sequestration reduces the H4Ac16 on the autosomal loci, resulting in a lowered expression. There is a concomitant increase of acetylation on the X chromosome, but little overall response of the X-linked genes (Fig 9).
|
In the SxlM and Sxlf; mle genotypes a low level of MSL-1/MSL-2 shows chromosomal binding to some degree, although present in distinct patterns in the two cases. This low level of binding, however, is insufficient to sequester all the available MOF present in the cell. Previous and present data suggest that in the absence of a functional MSL complex, MOF still associates with the chromosomes and is active in modifying H4. The reduced amount of MSL-1/MSL-2 appears saturated with MOF, allowing the remainder to be uniformly distributed across the genome, which modulates gene expression.
The general trends of X and autosomal gene expression in the SxlM and Sxlf mutants match the autoradiographic data of ![]()
A previous study has shown that the loss of individual components of the MSL complex in the msl mutant males releases the MOF acetylase from the X and a uniform H4 acetylation distribution results (![]()
![]()
The collective data indicate that models that posit an association of the MSL complex with a gene for dosage compensation to occur are not supported. First of all, genetic destruction of the complex does not eliminate dosage compensation of most X-linked genes (![]()
![]()
![]()
![]()
![]()
![]()
When these data are taken together along with previous studies on mle (![]()
![]()
![]()
| FOOTNOTES |
|---|
1 These authors contributed equally to this work. ![]()
| ACKNOWLEDGMENTS |
|---|
We are most grateful to J. C. Lucchesi, M. Kuroda, and P. Gergen for providing Drosophila stocks and antibodies to male-specific lethal proteins. This work was supported by a National Science Foundation research grant to J.A.B.
Manuscript received August 23, 1999; Accepted for publication February 28, 2000.
| LITERATURE CITED |
|---|
ADLER, D. A., E. I. RUGARLI, P. A. LINGENFELTER, K. TSUCHIYA, and D. POSLINSKI et al., 1997 Evidence of evolutionary up-regulation of the single active X chromosome in mammals based on Clc-4 expression levels in Mus spretus and Mus musculus.. Proc. Natl. Acad. Sci. USA 94:9244-9248
AMREIN, H. and R. AXEL, 1997 Genes expressed in neurons of adult male Drosophila. Cell 88:459-469[Medline].
ARKHIPOVA, I., J. LI, and M. MESELSON, 1997 On the mode of gene dosage compensation in Drosophila. Genetics 145:729-736[Abstract].
BAKER, B. S., M. GORMAN, and I. MARIN, 1994 Dosage compensation in Drosophila. Annu. Rev. Genet. 28:491-521[Medline].
BASHAW, G. J. and B. S. BAKER, 1995 The msl-2 dosage compensation gene of Drosophila encodes a putative DNA-binding protein whose expression is sex specifically regulated by Sex-lethal.. Development 121:3245-3258[Abstract].
BASHAW, G. J. and B. S. BAKER, 1997 The regulation of the Drosophila msl-2 gene reveals a function for Sex-lethal in translational control. Cell 87:789-798.
BELL, L. R., J. I. HORABIN, P. SCHEDL, and T. W. CLINE, 1991 Positive autoregulation of Sex-lethal by alternative splicing maintains the female determined state in Drosophila. Cell 65:229-239[Medline].
BERNSTEIN, M., R. A. LERSCH, L. SUBRAHMANYAN, and T. W. CLINE, 1995 Transposon insertions causing constitutive Sex-lethal activity in Drosophila melanogaster affect Sxl sex-specific transcript splicing. Genetics 139:631-648[Abstract].
BHADRA, U., M. PAL-BHADRA, and J. A. BIRCHLER, 1997 A trans-acting modifier of gene expression and suppressor of position-effect variegation in Drosophila. Mol. Gen. Genet. 254:621-634[Medline].
BHADRA, U., M. PAL-BHADRA, and J. A. BIRCHLER, 1998 Interactions among dosage-dependent trans-acting modifiers of gene expresssion and position effect variegation in Drosophila. Genetics 150:251-263
BHADRA, U., M. PAL-BHADRA, and J. A. BIRCHLER, 1999 Role of the male specific lethal (msl) genes in modifying the effects of sex chromosomal dosage in Drosophila. Genetics 152:249-268
BIRCHLER, J. A., 1979 A study of enzyme activities in a dosage series of the long arm of chromosome 1 in maize. Genetics 92:1211-1229
BIRCHLER, J. A., 1992 Expression of cis-regulatory mutations of the white locus in metafemales of Drosophila melanogaster.. Genet. Res. 59:11-18[Medline].
BIRCHLER, J. A., 1996 X chromosomal dosage compensation in Drosophila. Science 272:1190[Medline].
BIRCHLER, J. A. and K. J. NEWTON, 1981 Modulation of protein levels in chromosomal dosage series of maize: the biochemical basis of aneuploid syndromes. Genetics 99:247-266
CHARLESWORTH, B., 1996 The evolution of chromosomal sex determination and dosage compensation. Curr. Biol. 6:149-162[Medline].
CLINE, T. W., 1984 Autoregulatory functioning of a Drosophila gene product that establishes and maintains the sexually determined state. Genetics 107:231-277
CLINE, T. W., 1988 Evidence that sisterless-a and sisterless-b are two of several discrete `numerator elements' of the X/A sex determination signal in Drosophila that switch Sxl between two alternative stable expression states. Genetics 119:829-862
DEVLIN, R. H., D. G. HOLM, and T. A. GRIGLIATTI, 1988 The influence of whole-arm trisomy on gene expression in Drosophila. Genetics 118:87-101
ERICKSON, J. W. and T. W. CLINE, 1993 A bZIP protein, sisterless-a, collaborates with bHLH transcription factors early in Drosophila development to determine sex. Genes Dev. 7:1688-1702
FRANKE, A. and B. S. BAKER, 1999 The rox1 and rox2 RNAs are essential components of the compensasome, which mediates dosage compensation in Drosophila. Mol. Cell 4:117-122[Medline].
FROLOV, M. V., E. V. BENEVOLENSKAYA, and J. A. BIRCHLER, 1998 Regena (Rga), a Drosophila homolog of the global negative transcriptional regulator CDC36(NOT2) from yeast, modifies gene expression and suppresses position-effect variegation. Genetics 148:317-329
GORMAN, M., M. I. KURODA, and B. S. BAKER, 1993 Regulation of the sex-specified binding of the maleless dosage compensation protein to the male X-chromosomes in Drosophila. Cell 72:39-49[Medline].
GUO, M. and J. A. BIRCHLER, 1994 Trans-acting dosage effects on the expression of model gene systems in maize aneuploids. Science 266:1999-2002
HENIKOFF, S., 1979 Position effects and variegation enhancers in an autosomal region of Drosophila melanogaster.. Genetics 93:105-115
HENIKOFF, S., 1996 Dosage-dependent modification of position-effect variegation in Drosophila. Bioessays 18:401-409[Medline].
HIEBERT, J. C. and J. A. BIRCHLER, 1994 Effects of the maleless mutation on X and autosomal gene expression in Drosophila melanogaster.. Genetics 136:913-926[Abstract].
HILFIKER, A., D. HILFIKER-KLEINER, A. PANNUTI, and J. C. LUCCHESI, 1997 mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J. 16:2054-2060[Medline].
JIN, Y., Y. WANG, D. L. WALKER, H. DONG, and C. CONLEY et al., 1999 JIL-1: a novel chromosomal tandem kinase implicated in transcriptional regulation in Drosophila. Mol. Cell 4:129-135[Medline].
KELLEY, R. L. and M. I. KURODA, 1995 Equality for X chromosomes. Science 270:1607-1610
KELLEY, R. L., I. SOLOVYEVA, L. M. LYMAN, R. RICHMAN, and V. SOLOVYEV et al., 1995 Expression of msl-2 causes assembly of dosage compensation regulators on the X chromosomes and female lethality in Drosophila. Cell 81:867-877[Medline].
KELLEY, R. L., J. WANG, L. BELL, and M. I. KURODA, 1997 Sex lethal controls dosage compensation in Drosophila by a non-splicing mechanism. Nature 387:195-199[Medline].
KELLEY, R. L., V. H. MELLER, P. R. GORDADZE, G. ROMAN, and R. L. DAVIS et al., 1999 Epigenetic spreading of the Drosophila dosage compensation complex from roX RNA genes into flanking chromatin. Cell 98:513-522[Medline].
KURODA, M. I., M. KERNAN, R. KREBER, B. GANETZKY, and B. S. BAKER, 1991 The maleless protein associates with the X chromosome to regulate dosage compensation in Drosophila. Cell 66:935-947[Medline].
LUCCHESI, J. C. and T. SKRIPSKY, 1981 The link between dosage compensation and sex differentiation in Drosophila melanogaster.. Chromosoma 82:217-227[Medline].
LYMAN, L. M., K. COPPS, L. RASTELLI, R. L. KELLEY, and M. I. KURODA, 1997 Drosophila male-specific lethal-2 protein: structure/function analysis and dependence on MSL-1 for chromosome association. Genetics 147:1743-1753[Abstract].
MELLER, V. H., K. H. WU, G. ROMAN, M. I. KURODA, and R. L. DAVIS, 1997 roX1 RNA paints the X chromosome of male Drosophila and is regulated by the dosage compensation system. Cell 88:445-457[Medline].
RABINOW, L., A. T. NGUYEN-HUYNH, and J. A. BIRCHLER, 1991 A trans-acting regulatory gene that inversely affects the expression of the white, brown and scarlet loci in Drosophila. Genetics 129:463-480[Abstract].
TURNER, B. M., A. J. BIRLEY, and J. LAVENDER, 1992 Histone H4 isoforms acetylated at specific lysine residues define individual chromosomes and chromatin domains in Drosophila polytene nuclei. Cell 69:376-384.
This article has been cited by other articles:
![]() |
X. Deng and V. H. Meller roX RNAs Are Required for Increased Expression of X-Linked Genes in Drosophila melanogaster Males Genetics, December 1, 2006; 174(4): 1859 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pal Bhadra, U. Bhadra, and J. A. Birchler Misregulation of Sex-Lethal and Disruption of Male-Specific Lethal Complex Localization in Drosophila Species Hybrids Genetics, November 1, 2006; 174(3): 1151 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Straub, G. D. Gilfillan, V. K. Maier, and P. B. Becker The Drosophila MSL complex activates the transcription of target genes Genes & Dev., October 1, 2005; 19(19): 2284 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Morales, C. Regnard, A. Izzo, I. Vetter, and P. B. Becker The MRG Domain Mediates the Functional Integration of MSL3 into the Dosage Compensation Complex Mol. Cell. Biol., July 15, 2005; 25(14): 5947 - 5954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Molnar, Z. Ujfaludi, S. F. T. Fong, J. A. Bollinger, G. Waro, B. Fogelgren, D. M. Dooley, M. Mink, and K. Csiszar Drosophila Lysyl Oxidases Dmloxl-1 and Dmloxl-2 Are Differentially Expressed and the Active DmLOXL-1 Influences Gene Expression and Development J. Biol. Chem., June 17, 2005; 280(24): 22977 - 22985. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pal Bhadra, U. Bhadra, J. Kundu, and J. A. Birchler Gene Expression Analysis of the Function of the Male-Specific Lethal Complex in Drosophila Genetics, April 1, 2005; 169(4): 2061 - 2074. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |